Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study.
Barbanti P, Aurilia C, Cevoli S, Egeo G, Fofi L, Messina R, Salerno A, Torelli P, Albanese M, Carnevale A, Bono F, D'Amico D, Filippi M, Altamura C, Vernieri F; EARLY Study Group. Barbanti P, et al. Among authors: aurilia c. Headache. 2021 Oct;61(9):1351-1363. doi: 10.1111/head.14194. Epub 2021 Jul 26. Headache. 2021. PMID: 34309862
Tardive dyskinesias in the elderly.
Fabbrini G, Barbanti P, Aurilia C. Fabbrini G, et al. Among authors: aurilia c. Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S19-23. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps563>3.0.co;2-0. Int J Geriatr Psychiatry. 2001. PMID: 11748786 Review.
Migraine prophylaxis: what is new and what we need?
Barbanti P, Aurilia C, Egeo G, Fofi L. Barbanti P, et al. Among authors: aurilia c. Neurol Sci. 2011 May;32 Suppl 1:S111-5. doi: 10.1007/s10072-011-0526-3. Neurol Sci. 2011. PMID: 21533725 Review.
124 results